-
1
-
-
0035839136
-
Translating the histone code
-
Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293:1074-80.
-
(2001)
Science
, vol.293
, pp. 1074-1080
-
-
Jenuwein, T.1
Allis, C.D.2
-
2
-
-
0035883954
-
Transcription regulation by histone methylation: Interplay between different covalent modifications of the core histone tails
-
Zhang Y, Reinberg D. Transcription regulation by histone methylation: Interplay between different covalent modifications of the core histone tails. Genes Dev 2001; 15:2343-60.
-
(2001)
Genes Dev
, vol.15
, pp. 2343-2360
-
-
Zhang, Y.1
Reinberg, D.2
-
3
-
-
0141929385
-
Binary switches and modification cassettes in histone biology and beyond
-
Fischle W, Wang Y, Allis CD. Binary switches and modification cassettes in histone biology and beyond. Nature 2003; 425:475-9.
-
(2003)
Nature
, vol.425
, pp. 475-479
-
-
Fischle, W.1
Wang, Y.2
Allis, C.D.3
-
4
-
-
0035325163
-
Histone acetylation and chromatin remodeling
-
Gregory PD, Wagner K, Horz W. Histone acetylation and chromatin remodeling. Exp Cell Res 2001; 265:195-202.
-
(2001)
Exp Cell Res
, vol.265
, pp. 195-202
-
-
Gregory, P.D.1
Wagner, K.2
Horz, W.3
-
5
-
-
0032030770
-
Histone acetylation and transcriptional regulatory mechanisms
-
Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 1998; 12:599-606.
-
(1998)
Genes Dev
, vol.12
, pp. 599-606
-
-
Struhl, K.1
-
6
-
-
0034596309
-
Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
-
Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000; 92:1210-6.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 1210-1216
-
-
Marks, P.A.1
Richon, V.M.2
Rifkind, R.A.3
-
7
-
-
0034908978
-
Inhibitors of histone deacetylase are potentially effective anticancer agents
-
Marks PA, Rifkind RA, Richon VM, Breslow R. Inhibitors of histone deacetylase are potentially effective anticancer agents. Clin Cancer Res 2001; 7:759-60.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 759-760
-
-
Marks, P.A.1
Rifkind, R.A.2
Richon, V.M.3
Breslow, R.4
-
8
-
-
0029022770
-
Rubinstein-Taybi syndrome caused by mutations in the transcriptional coactivator CBP
-
Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RC, Masuno M, Tommerup N, van Ommen GJ, Goodman RH, Peters DJ, et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional coactivator CBP. Nature 1995; 376:348-51.
-
(1995)
Nature
, vol.376
, pp. 348-351
-
-
Petrij, F.1
Giles, R.H.2
Dauwerse, H.G.3
Saris, J.J.4
Hennekam, R.C.5
Masuno, M.6
Tommerup, N.7
Van Ommen, G.J.8
Goodman, R.H.9
Peters, D.J.10
-
9
-
-
0036527775
-
Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
-
Johnstone RW. Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer. Nat Rev Drug Discov 2002; 1:287-99.
-
(2002)
Nat Rev Drug Discov
, vol.1
, pp. 287-299
-
-
Johnstone, R.W.1
-
10
-
-
0024996768
-
Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A
-
Yoshida M, Kijima M, Akita M, Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 1990; 265:17174-9.
-
(1990)
J Biol Chem
, vol.265
, pp. 17174-17179
-
-
Yoshida, M.1
Kijima, M.2
Akita, M.3
Beppu, T.4
-
12
-
-
0033539092
-
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
-
Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R, Pavletich NP. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 1999; 401:188-193.
-
(1999)
Nature
, vol.401
, pp. 188-193
-
-
Finnin, M.S.1
Donigian, J.R.2
Cohen, A.3
Richon, V.M.4
Rifkind, R.A.5
Marks, P.A.6
Breslow, R.7
Pavletich, N.P.8
-
13
-
-
0032539890
-
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
-
USA
-
Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA, Marks PA. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci USA 1998; 95:3003-7.
-
(1998)
Proc Natl Acad Sci
, vol.95
, pp. 3003-3007
-
-
Richon, V.M.1
Emiliani, S.2
Verdin, E.3
Webb, Y.4
Breslow, R.5
Rifkind, R.A.6
Marks, P.A.7
-
14
-
-
0037039919
-
Structure and chemistry of apicidins, a class of novel cyclic tetrapeptides without a terminal alpha-keto epoxide as inhibitors of histone deacetylase with potent antiprotozoal activities
-
Singh SB, Zink DL, Liesch JM, Mosley RT, Dombrowski AW, Bills GF, Darkin-Rattray SJ, Schmatz DM, Goetz MA. Structure and chemistry of apicidins, a class of novel cyclic tetrapeptides without a terminal alpha-keto epoxide as inhibitors of histone deacetylase with potent antiprotozoal activities. J Org Chem 2002; 67:815-25.
-
(2002)
J Org Chem
, vol.67
, pp. 815-825
-
-
Singh, S.B.1
Zink, D.L.2
Liesch, J.M.3
Mosley, R.T.4
Dombrowski, A.W.5
Bills, G.F.6
Darkin-Rattray, S.J.7
Schmatz, D.M.8
Goetz, M.A.9
-
15
-
-
0035793107
-
Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin
-
USA
-
Furumai R, Komatsu Y, Nishino N, Khochbin S, Yoshida M, Horinouchi S. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Proc Natl Acad Sci USA 2001; 98:87-92.
-
(2001)
Proc Natl Acad Sci
, vol.98
, pp. 87-92
-
-
Furumai, R.1
Komatsu, Y.2
Nishino, N.3
Khochbin, S.4
Yoshida, M.5
Horinouchi, S.6
-
16
-
-
0036735385
-
FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases
-
Furumai R, Matsuyama A, Kobashi N, Lee KH, Nishiyama M, Nakajima H, Tanaka A, Komatsu Y, Nishino N, Yoshida M, Horinouchi S. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. Cancer Res 2002; 62:4916-21.
-
(2002)
Cancer Res
, vol.62
, pp. 4916-4921
-
-
Furumai, R.1
Matsuyama, A.2
Kobashi, N.3
Lee, K.H.4
Nishiyama, M.5
Nakajima, H.6
Tanaka, A.7
Komatsu, Y.8
Nishino, N.9
Yoshida, M.10
Horinouchi, S.11
-
17
-
-
0033551152
-
A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors
-
USA
-
Saito A, Yamashita T, Mariko Y, Nosaka Y, Tsuchiya K, Ando T, Suzuki T, Tsuruo T, Nakanishi O. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci USA 1999; 96:4592-7.
-
(1999)
Proc Natl Acad Sci
, vol.96
, pp. 4592-4597
-
-
Saito, A.1
Yamashita, T.2
Mariko, Y.3
Nosaka, Y.4
Tsuchiya, K.5
Ando, T.6
Suzuki, T.7
Tsuruo, T.8
Nakanishi, O.9
-
18
-
-
0035098155
-
Chronic oral administration of CI-994: A phase 1 study
-
Prakash S, Foster BJ, Meyer M, Wozniak A, Heilbrun LK, Flaherty L, Zalupski M, Radulovic L, Valdivieso M, LoRusso PM. Chronic oral administration of CI-994: A phase 1 study. Invest New Drugs 2001; 19:1-11.
-
(2001)
Invest New Drugs
, vol.19
, pp. 1-11
-
-
Prakash, S.1
Foster, B.J.2
Meyer, M.3
Wozniak, A.4
Heilbrun, L.K.5
Flaherty, L.6
Zalupski, M.7
Radulovic, L.8
Valdivieso, M.9
Lorusso, P.M.10
-
19
-
-
18644379759
-
Trifluoromethyl ketones as inhibitors of histone deacetylase
-
Frey RR, Wada CK, Garland RB, Curtin ML, Michaelides MR, Li J, Pease LJ, Glaser KB, Marcotte PA, Bouska JJ, Murphy SS, Davidsen SK. Trifluoromethyl ketones as inhibitors of histone deacetylase. Bioorg Med Chem Lett 2002; 12:3443-7.
-
(2002)
Bioorg Med Chem Lett
, vol.12
, pp. 3443-3447
-
-
Frey, R.R.1
Wada, C.K.2
Garland, R.B.3
Curtin, M.L.4
Michaelides, M.R.5
Li, J.6
Pease, L.J.7
Glaser, K.B.8
Marcotte, P.A.9
Bouska, J.J.10
Murphy, S.S.11
Davidsen, S.K.12
-
20
-
-
0035965343
-
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
-
Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001; 276:36734-41.
-
(2001)
J Biol Chem
, vol.276
, pp. 36734-36741
-
-
Phiel, C.J.1
Zhang, F.2
Huang, E.Y.3
Guenther, M.G.4
Lazar, M.A.5
Klein, P.S.6
-
22
-
-
13944284147
-
Specific and redundant functions of histone deacetylases in regulation of cell cycle and apoptosis
-
Zhu P, Huber E, Kiefer F, Gottlicher M. Specific and redundant functions of histone deacetylases in regulation of cell cycle and apoptosis. Cell Cycle 2004; 3:1240-2.
-
(2004)
Cell Cycle
, vol.3
, pp. 1240-1242
-
-
Zhu, P.1
Huber, E.2
Kiefer, F.3
Gottlicher, M.4
-
24
-
-
0035048449
-
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes
-
Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW, Moon EJ, Kim HS, Lee SK, Chung HY, Kim CW, Kim KW. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 2001; 7:437-43.
-
(2001)
Nat Med
, vol.7
, pp. 437-443
-
-
Kim, M.S.1
Kwon, H.J.2
Lee, Y.M.3
Baek, J.H.4
Jang, J.E.5
Lee, S.W.6
Moon, E.J.7
Kim, H.S.8
Lee, S.K.9
Chung, H.Y.10
Kim, C.W.11
Kim, K.W.12
-
25
-
-
9144220841
-
Transcriptional signature of histone deacetylase inhibition in multiple myeloma: Biological and clinical implications
-
USA
-
Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Hideshima T, Akiyama M, Chauhan D, Munshi N, Gu X, Bailey C, Joseph M, Libermann TA, Richon VM, Marks PA, Anderson KC. Transcriptional signature of histone deacetylase inhibition in multiple myeloma: Biological and clinical implications. Proc Natl Acad Sci USA 2004; 101:540-5.
-
(2004)
Proc Natl Acad Sci
, vol.101
, pp. 540-545
-
-
Mitsiades, C.S.1
Mitsiades, N.S.2
McMullan, C.J.3
Poulaki, V.4
Shringarpure, R.5
Hideshima, T.6
Akiyama, M.7
Chauhan, D.8
Munshi, N.9
Gu, X.10
Bailey, C.11
Joseph, M.12
Libermann, T.A.13
Richon, V.M.14
Marks, P.A.15
Anderson, K.C.16
-
26
-
-
21244464349
-
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
-
Kelly WK, O'Connor OA, Krug LM, Chiao JH, Heaney M, Curley T, MacGregoreCortelli B, Tong W, Secrist JP, Schwartz L, Richardson S, Chu E, Olgac S, Marks PA, Scher H, Richon VM. Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. J Clin Oncol 2005; 23:3923-31.
-
(2005)
J Clin Oncol
, vol.23
, pp. 3923-3931
-
-
Kelly, W.K.1
O'Connor, O.A.2
Krug, L.M.3
Chiao, J.H.4
Heaney, M.5
Curley, T.6
MacGregorecortelli, B.7
Tong, W.8
Secrist, J.P.9
Schwartz, L.10
Richardson, S.11
Chu, E.12
Olgac, S.13
Marks, P.A.14
Scher, H.15
Richon, V.M.16
-
27
-
-
12444321545
-
Phase I clinical trial of histone deacetylase inhibitor: Suberoylanilide hydroxamic acid administered intravenously
-
Kelly WK, Richon VM, O'Connor O, Curley T, MacGregor-Curtelli B, Tong W, Klang M, Schwartz L, Richardson S, Rosa E, Drobnjak M, Cordon-Cordo C, Chiao JH, Rifkind R, Marks PA, Scher H. Phase I clinical trial of histone deacetylase inhibitor: Suberoylanilide hydroxamic acid administered intravenously. Clin Cancer Res 2003; 9:3578-88.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 3578-3588
-
-
Kelly, W.K.1
Richon, V.M.2
O'Connor, O.3
Curley, T.4
MacGregor-Curtelli, B.5
Tong, W.6
Klang, M.7
Schwartz, L.8
Richardson, S.9
Rosa, E.10
Drobnjak, M.11
Cordon-Cordo, C.12
Chiao, J.H.13
Rifkind, R.14
Marks, P.A.15
Scher, H.16
-
28
-
-
20444479514
-
Drug insight: Histone deacetylase inhibitors-development of the new targeted anticancer agent suberoylanilide hydroxamic acid
-
Kelly WK, Marks PA. Drug insight: Histone deacetylase inhibitors-development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nat Clin Pract Oncol 2005; 2:150-7.
-
(2005)
Nat Clin Pract Oncol
, vol.2
, pp. 150-157
-
-
Kelly, W.K.1
Marks, P.A.2
-
29
-
-
21744444434
-
Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies
-
Blaheta RA, Michaelis M, Driever PH, Cinatl Jr J. Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies. Med Res Rev 2005; 25:383-97.
-
(2005)
Med Res Rev
, vol.25
, pp. 383-397
-
-
Blaheta, R.A.1
Michaelis, M.2
Driever, P.H.3
Cinatl Jr., J.4
-
30
-
-
2942535832
-
T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: Impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance
-
Piekarz RL, Robey RW, Zhan Z, Kayastha G, Sayah A, Abdeldaim AH, Torrico S, Bates SE. T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: Impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance. Blood 2004; 103:4636-43.
-
(2004)
Blood
, vol.103
, pp. 4636-4643
-
-
Piekarz, R.L.1
Robey, R.W.2
Zhan, Z.3
Kayastha, G.4
Sayah, A.5
Abdeldaim, A.H.6
Torrico, S.7
Bates, S.E.8
-
32
-
-
25144487124
-
Mechanisms of selective anticancer action of histone deacetylase inhibitors
-
Insinga A, Minucci S, Pelicci PG. Mechanisms of selective anticancer action of histone deacetylase inhibitors. Cell Cycle 2005; 4:741-3.
-
(2005)
Cell Cycle
, vol.4
, pp. 741-743
-
-
Insinga, A.1
Minucci, S.2
Pelicci, P.G.3
-
33
-
-
26444439216
-
Prospects: Histone deacetylase inhibitors
-
Dokmanovic M, Marks PA. Prospects: Histone deacetylase inhibitors. J Cell Biochem 2005; 96:293-304.
-
(2005)
J Cell Biochem
, vol.96
, pp. 293-304
-
-
Dokmanovic, M.1
Marks, P.A.2
-
34
-
-
18444414332
-
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression
-
Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T, Seiser C. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. Embo J 2002; 21:2672-81.
-
(2002)
Embo J
, vol.21
, pp. 2672-2681
-
-
Lagger, G.1
O'Carroll, D.2
Rembold, M.3
Khier, H.4
Tischler, J.5
Weitzer, G.6
Schuettengruber, B.7
Hauser, C.8
Brunmeir, R.9
Jenuwein, T.10
Seiser, C.11
-
35
-
-
0034654011
-
Acetylation: A regulatory modification to rival phosphorylation?
-
Kouzarides T. Acetylation: A regulatory modification to rival phosphorylation? Embo J 2000; 19:1176-9.
-
(2000)
Embo J
, vol.19
, pp. 1176-1179
-
-
Kouzarides, T.1
-
36
-
-
4143128717
-
Acetylation of proteins as novel target for antitumor therapy: Review article
-
Di Gennaro E, Bruzzese F, Caraglia M, Abruzzese A, Budillon A. Acetylation of proteins as novel target for antitumor therapy: Review article. Amino Acids 2004; 26:435-41.
-
(2004)
Amino Acids
, vol.26
, pp. 435-441
-
-
Di Gennaro, E.1
Bruzzese, F.2
Caraglia, M.3
Abruzzese, A.4
Budillon, A.5
-
37
-
-
0037444803
-
Histone deacetylases (HDACs): Characterization of the classical HDAC family
-
de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem J 2003; 370:737-49.
-
(2003)
Biochem J
, vol.370
, pp. 737-749
-
-
Ruijter, A.J.1
Van Gennip, A.H.2
Caron, H.N.3
Kemp, S.4
Van Kuilenburg, A.B.5
-
38
-
-
0036008097
-
Deacetylase enzymes: Biological functions and the use of small-molecule inhibitors
-
Grozinger CM, Schreiber SL. Deacetylase enzymes: Biological functions and the use of small-molecule inhibitors. Chem Biol 2002; 9:3-16.
-
(2002)
Chem Biol
, vol.9
, pp. 3-16
-
-
Grozinger, C.M.1
Schreiber, S.L.2
-
40
-
-
29144484694
-
Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia
-
Bug G, Ritter M, Wassmann B, Schoch C, Heinzel T, Schwarz K, Romanski A, Kramer OH, Kampfmann M, Hoelzer D, Neubauer A, Ruthardt M, Ottmann OG. Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia. Cancer 2005; 104:2717-25.
-
(2005)
Cancer
, vol.104
, pp. 2717-2725
-
-
Bug, G.1
Ritter, M.2
Wassmann, B.3
Schoch, C.4
Heinzel, T.5
Schwarz, K.6
Romanski, A.7
Kramer, O.H.8
Kampfmann, M.9
Hoelzer, D.10
Neubauer, A.11
Ruthardt, M.12
Ottmann, O.G.13
-
41
-
-
0242610850
-
Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA
-
Kim MS, Blake M, Baek JH, Kohlhagen G, Pommier Y, Carrier F. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res 2003; 63:7291-300.
-
(2003)
Cancer Res
, vol.63
, pp. 7291-7300
-
-
Kim, M.S.1
Blake, M.2
Baek, J.H.3
Kohlhagen, G.4
Pommier, Y.5
Carrier, F.6
-
42
-
-
22344444291
-
Modulation of sensitivity to doxorubicin by the histone deacetylase inhibitor sodium butyrate in breast cancer cells
-
Louis M, Rosato RR, Battaglia E, Neguesque A, Lapotre A, Grant S, Bagrel D. Modulation of sensitivity to doxorubicin by the histone deacetylase inhibitor sodium butyrate in breast cancer cells. Int J Oncol 2005; 26:1569-74.
-
(2005)
Int J Oncol
, vol.26
, pp. 1569-1574
-
-
Louis, M.1
Rosato, R.R.2
Battaglia, E.3
Neguesque, A.4
Lapotre, A.5
Grant, S.6
Bagrel, D.7
-
43
-
-
20544471104
-
Histone deacetylase inhibitors in programmed cell death and cancer therapy
-
Marks PA, Jiang X. Histone deacetylase inhibitors in programmed cell death and cancer therapy. Cell Cycle 2005; 4:549-51.
-
(2005)
Cell Cycle
, vol.4
, pp. 549-551
-
-
Marks, P.A.1
Jiang, X.2
-
44
-
-
0141885037
-
From discovery to the coming generation of histone deacetylase inhibitors
-
Yoshida M, Matsuyama A, Komatsu Y, Nishino N. From discovery to the coming generation of histone deacetylase inhibitors. Curr Med Chem 2003; 10:2351-8.
-
(2003)
Curr Med Chem
, vol.10
, pp. 2351-2358
-
-
Yoshida, M.1
Matsuyama, A.2
Komatsu, Y.3
Nishino, N.4
-
45
-
-
13844309711
-
Clinical development of histone deacetylase inhibitors as anticancer agents
-
Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC. Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol 2005; 45:495-528.
-
(2005)
Annu Rev Pharmacol Toxicol
, vol.45
, pp. 495-528
-
-
Drummond, D.C.1
Noble, C.O.2
Kirpotin, D.B.3
Guo, Z.4
Scott, G.K.5
Benz, C.C.6
-
46
-
-
0036401554
-
Pharmacological and therapeutic properties of valproate: A summary after 35 years of clinical experience
-
Perucca E. Pharmacological and therapeutic properties of valproate: A summary after 35 years of clinical experience. CNS Drugs 2002; 16:695-714.
-
(2002)
CNS Drugs
, vol.16
, pp. 695-714
-
-
Perucca, E.1
-
47
-
-
0021949012
-
Treatment of status epilepticus in children with rectal sodium valproate
-
Snead IIIrd OC, Miles MV. Treatment of status epilepticus in children with rectal sodium valproate. J Pediatr 1985; 106:323-5.
-
(1985)
J Pediatr
, vol.106
, pp. 323-325
-
-
Snead III, O.C.1
Miles, M.V.2
-
48
-
-
0037742375
-
Valproate: A reappraisal of its pharmacodynamic properties and mechanisms of action
-
Loscher W. Valproate: A reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 1999; 58:31-59.
-
(1999)
Prog Neurobiol
, vol.58
, pp. 31-59
-
-
Loscher, W.1
-
49
-
-
0842325787
-
Histone deacetylase is a target of valproic acid-mediated cellular differentiation
-
Gurvich N, Tsygankova OM, Meinkoth JL, Klein PS. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res 2004; 64:1079-86.
-
(2004)
Cancer Res
, vol.64
, pp. 1079-1086
-
-
Gurvich, N.1
Tsygankova, O.M.2
Meinkoth, J.L.3
Klein, P.S.4
-
50
-
-
29144481615
-
Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia
-
Kuendgen A, Knipp S, Fox F, Strupp C, Hildebrandt B, Steidl C, Germing U, Haas R, Gattermann N. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia. Ann Hematol 2005; 1-6.
-
(2005)
Ann Hematol
, pp. 1-6
-
-
Kuendgen, A.1
Knipp, S.2
Fox, F.3
Strupp, C.4
Hildebrandt, B.5
Steidl, C.6
Germing, U.7
Haas, R.8
Gattermann, N.9
-
51
-
-
21744442937
-
The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells
-
Trus MR, Yang L, Suarez Saiz F, Bordeleau L, Jurisica I, Minden MD. The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells. Leukemia 2005; 19:1161-8.
-
(2005)
Leukemia
, vol.19
, pp. 1161-1168
-
-
Trus, M.R.1
Yang, L.2
Suarez Saiz, F.3
Bordeleau, L.4
Jurisica, I.5
Minden, M.D.6
-
52
-
-
18244376609
-
Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model
-
Touma SE, Goldberg JS, Moench P, Guo X, Tickoo SK, Gudas LJ, Nanus DM. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model. Clin Cancer Res 2005; 11:3558-66.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 3558-3566
-
-
Touma, S.E.1
Goldberg, J.S.2
Moench, P.3
Guo, X.4
Tickoo, S.K.5
Gudas, L.J.6
Nanus, D.M.7
-
53
-
-
18844415633
-
Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA)
-
Kim MS, Baek JH, Chakravarty D, Sidransky D, Carrier F. Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA). Exp Cell Res 2005; 306:94-102.
-
(2005)
Exp Cell Res
, vol.306
, pp. 94-102
-
-
Kim, M.S.1
Baek, J.H.2
Chakravarty, D.3
Sidransky, D.4
Carrier, F.5
-
54
-
-
0036849052
-
Modelling the effect of incorporated halogenated pyrimidine on radiation-induced DNA strand breaks
-
Watanabe R, Nikjoo H. Modelling the effect of incorporated halogenated pyrimidine on radiation-induced DNA strand breaks. Int J Radiat Biol 2002; 78:953-66.
-
(2002)
Int J Radiat Biol
, vol.78
, pp. 953-966
-
-
Watanabe, R.1
Nikjoo, H.2
-
55
-
-
0034050958
-
Preclinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine radiosensitization in U251 human glioblastoma xenografts
-
Kinsella TJ, Vielhuber KA, Kunugi KA, Schupp J, Davis TW, Sands H. Preclinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine radiosensitization in U251 human glioblastoma xenografts. Clin Cancer Res 2000; 6:1468-75.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1468-1475
-
-
Kinsella, T.J.1
Vielhuber, K.A.2
Kunugi, K.A.3
Schupp, J.4
Davis, T.W.5
Sands, H.6
-
56
-
-
1942439101
-
A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer
-
Chan P, Milosevic M, Fyles A, Carson J, Pintilie M, Rauth M, Thomas G. A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer. Radiother Oncol 2004; 70:295-9.
-
(2004)
Radiother Oncol
, vol.70
, pp. 295-299
-
-
Chan, P.1
Milosevic, M.2
Fyles, A.3
Carson, J.4
Pintilie, M.5
Rauth, M.6
Thomas, G.7
-
57
-
-
2642527700
-
Efaproxiral: A novel radiation sensitiser
-
Suh JH. Efaproxiral: A novel radiation sensitiser. Expert Opin Investig Drugs 2004; 13:543-50.
-
(2004)
Expert Opin Investig Drugs
, vol.13
, pp. 543-550
-
-
Suh, J.H.1
-
58
-
-
32244438753
-
Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: Comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection
-
Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, Broude EV, Blagosklonny MV. Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: Comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection. Cell Death Differ 2005; In press.
-
(2005)
Cell Death Differ
-
-
Demidenko, Z.N.1
Vivo, C.2
Halicka, H.D.3
Li, C.J.4
Bhalla, K.5
Broude, E.V.6
Blagosklonny, M.V.7
-
59
-
-
0012177733
-
Cyclotherapy: Protection of normal cells and unshielding of cancer cells
-
Blagosklonny MV, Darzynkiewicz Z. Cyclotherapy: Protection of normal cells and unshielding of cancer cells. Cell Cycle 2002; 1:375-82.
-
(2002)
Cell Cycle
, vol.1
, pp. 375-382
-
-
Blagosklonny, M.V.1
Darzynkiewicz, Z.2
-
60
-
-
0023176048
-
Effects of nucleoside analogs and sodium butyrate on recovery from potentially lethal X ray damage in human colon tumor cells
-
Arundel CM, Leith JT. Effects of nucleoside analogs and sodium butyrate on recovery from potentially lethal X ray damage in human colon tumor cells. Int J Radiat Oncol Biol Phys 1987; 13:593-601.
-
(1987)
Int J Radiat Oncol Biol Phys
, vol.13
, pp. 593-601
-
-
Arundel, C.M.1
Leith, J.T.2
-
61
-
-
0023924695
-
Effects of sodium butyrate and 3-aminobenzamide on survival of Chinese hamster HA-1 cells after X irradiation
-
Leith JT. Effects of sodium butyrate and 3-aminobenzamide on survival of Chinese hamster HA-1 cells after X irradiation. Radiat Res 1988; 114:186-91.
-
(1988)
Radiat Res
, vol.114
, pp. 186-191
-
-
Leith, J.T.1
-
62
-
-
0022366477
-
Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate (NaB)
-
Arundel CM, Glicksman AS, Leith JT. Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate (NaB). Radiat Res 1985; 104:443-8.
-
(1985)
Radiat Res
, vol.104
, pp. 443-448
-
-
Arundel, C.M.1
Glicksman, A.S.2
Leith, J.T.3
-
63
-
-
0034088092
-
A novel approach for nasopharyngeal carcinoma treatment uses phenylbutyrate as a protein kinase C modulator: Implications for radiosensitization and EBV-targeted therapy
-
Chung YL, Lee YH, Yen SH, Chi KH. A novel approach for nasopharyngeal carcinoma treatment uses phenylbutyrate as a protein kinase C modulator: Implications for radiosensitization and EBV-targeted therapy. Clin Cancer Res 2000; 6:1452-8.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1452-1458
-
-
Chung, Y.L.1
Lee, Y.H.2
Yen, S.H.3
Chi, K.H.4
-
64
-
-
0034769471
-
Chemical agents that promote chromatin compaction radiosensitize tumour cells
-
Biade S, Stobbe CC, Boyd JT, Chapman JD. Chemical agents that promote chromatin compaction radiosensitize tumour cells. Int J Radiat Biol 2001; 77:1033-42.
-
(2001)
Int J Radiat Biol
, vol.77
, pp. 1033-1042
-
-
Biade, S.1
Stobbe, C.C.2
Boyd, J.T.3
Chapman, J.D.4
-
65
-
-
27644586649
-
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity
-
Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML, Tucker SL, Ismail S, Stevens C, Meyn RE. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res 2005; 11:4912-2.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 4912-4912
-
-
Munshi, A.1
Kurland, J.F.2
Nishikawa, T.3
Tanaka, T.4
Hobbs, M.L.5
Tucker, S.L.6
Ismail, S.7
Stevens, C.8
Meyn, R.E.9
-
66
-
-
3042568739
-
Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor
-
Kim JH, Shin JH, Kim IH. Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor. Int J Radiat Oncol Biol Phys 2004; 59:1174-80.
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.59
, pp. 1174-1180
-
-
Kim, J.H.1
Shin, J.H.2
Kim, I.H.3
-
67
-
-
23844544658
-
Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death
-
Nome RV, Bratland A, Harman G, Fodstad O, Andersson Y, Ree AH. Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death. Mol Cancer Ther 2005; 4:1231-8.
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 1231-1238
-
-
Nome, R.V.1
Bratland, A.2
Harman, G.3
Fodstad, O.4
Andersson, Y.5
Ree, A.H.6
-
68
-
-
3042618526
-
Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors
-
Zhang Y, Jung M, Dritschilo A, Jung M. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors. Radiat Res 2004; 161:667-4.
-
(2004)
Radiat Res
, vol.161
, pp. 667-674
-
-
Zhang, Y.1
Jung, M.2
Dritschilo, A.3
Jung, M.4
-
69
-
-
19444376297
-
Novel HDAC inhibitors with radiosensitizing properties
-
Jung M, Velena A, Chen B, Petukhov PA, Kozikowski AP, Dritschilo A. Novel HDAC inhibitors with radiosensitizing properties. Radiat Res 2005; 163:488-93.
-
(2005)
Radiat Res
, vol.163
, pp. 488-493
-
-
Jung, M.1
Velena, A.2
Chen, B.3
Petukhov, P.A.4
Kozikowski, A.P.5
Dritschilo, A.6
-
70
-
-
25144451310
-
The histone deacetylase inhibitor, trichostatin a, enhances radiation sensitivity and accumulation of gammaH2A.X
-
Karagiannis TC, Kn H, El-Osta A. The histone deacetylase inhibitor, trichostatin a, enhances radiation sensitivity and accumulation of gammaH2A.X. Cancer Biol Ther 2005; 4:787-93.
-
(2005)
Cancer Biol Ther
, vol.4
, pp. 787-793
-
-
Karagiannis, T.C.1
Kn, H.2
El-Osta, A.3
-
71
-
-
14044250159
-
Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid
-
Camphausen K, Cerna D, Scott T, Sproull M, Burgan WE, Cerra MA, Fine H, Tofilon PJ. Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. Int J Cancer 2005; 114:380-6.
-
(2005)
Int J Cancer
, vol.114
, pp. 380-386
-
-
Camphausen, K.1
Cerna, D.2
Scott, T.3
Sproull, M.4
Burgan, W.E.5
Cerra, M.A.6
Fine, H.7
Tofilon, P.J.8
-
72
-
-
17844381019
-
Modulation of radiation response by histone deacetylase inhibition
-
Chinnaiyan P, Vallabhaneni G, Armstrong E, Huang SM, Harari PM. Modulation of radiation response by histone deacetylase inhibition. Int J Radiat Oncol Biol Phys 2005; 62:223-9.
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.62
, pp. 223-229
-
-
Chinnaiyan, P.1
Vallabhaneni, G.2
Armstrong, E.3
Huang, S.M.4
Harari, P.M.5
-
73
-
-
2342564962
-
Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3- yl-methoxycarbonyl)amino-methyl] benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells
-
Zhang Y, Adachi M, Zhao X, Kawamura R, Imai K. Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)amino- methyl] benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells. Int J Cancer 2004; 110:301-8.
-
(2004)
Int J Cancer
, vol.110
, pp. 301-308
-
-
Zhang, Y.1
Adachi, M.2
Zhao, X.3
Kawamura, R.4
Imai, K.5
-
74
-
-
4644259264
-
Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation
-
Camphausen K, Scott T, Sproull M, Tofilon PJ. Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation. Clin Cancer Res 2004; 10:6066-71.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 6066-6071
-
-
Camphausen, K.1
Scott, T.2
Sproull, M.3
Tofilon, P.J.4
-
75
-
-
1642576220
-
Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275
-
Camphausen K, Burgan W, Cerra M, Oswald KA, Trepel JB, Lee MJ, Tofilon PJ. Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275. Cancer Res 2004; 64:316-21.
-
(2004)
Cancer Res
, vol.64
, pp. 316-321
-
-
Camphausen, K.1
Burgan, W.2
Cerra, M.3
Oswald, K.A.4
Trepel, J.B.5
Lee, M.J.6
Tofilon, P.J.7
-
76
-
-
0035093737
-
DNA double-strand breaks: Signaling, repair and the cancer connection
-
Khanna KK, Jackson SP. DNA double-strand breaks: Signaling, repair and the cancer connection. Nat Genet 2001; 27:247-54.
-
(2001)
Nat Genet
, vol.27
, pp. 247-254
-
-
Khanna, K.K.1
Jackson, S.P.2
-
77
-
-
0032493889
-
Saccharomyces Ku70, mre11/rad50 and RPA proteins regulate adaptation to G2/M arrest after DNA damage
-
Lee SE, Moore JK, Holmes A, Umezu K, Kolodner RD, Haber JE. Saccharomyces Ku70, mre11/rad50 and RPA proteins regulate adaptation to G2/M arrest after DNA damage. Cell 1998; 94:399-409.
-
(1998)
Cell
, vol.94
, pp. 399-409
-
-
Lee, S.E.1
Moore, J.K.2
Holmes, A.3
Umezu, K.4
Kolodner, R.D.5
Haber, J.E.6
-
78
-
-
0034641963
-
Defying death after DNA damage
-
Rich T, Allen RL, Wyllie AH. Defying death after DNA damage. Nature 2000; 407:777-83.
-
(2000)
Nature
, vol.407
, pp. 777-783
-
-
Rich, T.1
Allen, R.L.2
Wyllie, A.H.3
-
79
-
-
0035839840
-
DNA double strand break repair and chromosomal translocation: Lessons from animal models
-
Ferguson DO, Alt FW. DNA double strand break repair and chromosomal translocation: Lessons from animal models. Oncogene 2001; 20:5572-9.
-
(2001)
Oncogene
, vol.20
, pp. 5572-5579
-
-
Ferguson, D.O.1
Alt, F.W.2
-
80
-
-
0034621854
-
Frequent chromosomal translocations induced by DNA double-strand breaks
-
Richardson C, Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 2000; 405:697-700.
-
(2000)
Nature
, vol.405
, pp. 697-700
-
-
Richardson, C.1
Jasin, M.2
-
81
-
-
0032489520
-
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
-
Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858-68.
-
(1998)
J Biol Chem
, vol.273
, pp. 5858-5868
-
-
Rogakou, E.P.1
Pilch, D.R.2
Orr, A.H.3
Ivanova, V.S.4
Bonner, W.M.5
-
82
-
-
0032861343
-
Megabase chromatin domains involved in DNA double-strand breaks in vivo
-
Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 1999; 146:905-16.
-
(1999)
J Cell Biol
, vol.146
, pp. 905-916
-
-
Rogakou, E.P.1
Boon, C.2
Redon, C.3
Bonner, W.M.4
-
83
-
-
0037711771
-
Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks
-
Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, Bonner RF, Bonner WM, Nussenzweig A. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol 2003; 5:675-9.
-
(2003)
Nat Cell Biol
, vol.5
, pp. 675-679
-
-
Celeste, A.1
Fernandez-Capetillo, O.2
Kruhlak, M.J.3
Pilch, D.R.4
Staudt, D.W.5
Lee, A.6
Bonner, R.F.7
Bonner, W.M.8
Nussenzweig, A.9
-
84
-
-
0343280013
-
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
-
Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000; 10:886-95.
-
(2000)
Curr Biol
, vol.10
, pp. 886-895
-
-
Paull, T.T.1
Rogakou, E.P.2
Yamazaki, V.3
Kirchgessner, C.U.4
Gellert, M.5
Bonner, W.M.6
-
85
-
-
0942278942
-
Phosphorylation of histone H2AX as a measure of radiosensitivity
-
Olive PL, Banath JP. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys 2004; 58:331-5.
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.58
, pp. 331-335
-
-
Olive, P.L.1
Banath, J.P.2
-
86
-
-
0035449355
-
Cell cycle checkpoint signaling through the ATM and ATR kinases
-
Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 2001; 15:2177-96.
-
(2001)
Genes Dev
, vol.15
, pp. 2177-2196
-
-
Abraham, R.T.1
-
87
-
-
0034437671
-
Multiple signaling pathways involving ATM
-
Kastan MB, Lim DS, Kim ST, Xu B, Canman C. Multiple signaling pathways involving ATM. Cold Spring Harb Symp Quant Biol 2000; 65:521-6.
-
(2000)
Cold Spring Harb Symp Quant Biol
, vol.65
, pp. 521-526
-
-
Kastan, M.B.1
Lim, D.S.2
Kim, S.T.3
Xu, B.4
Canman, C.5
-
88
-
-
0033555260
-
A role for ATR in the DNA damage-induced phosphorylation of p53
-
Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C, Abraham RT. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 1999; 13:152-7.
-
(1999)
Genes Dev
, vol.13
, pp. 152-157
-
-
Tibbetts, R.S.1
Brumbaugh, K.M.2
Williams, J.M.3
Sarkaria, J.N.4
Cliby, W.A.5
Shieh, S.Y.6
Taya, Y.7
Prives, C.8
Abraham, R.T.9
-
89
-
-
28444465447
-
ATM signaling and 53BP1
-
Zgheib O, Huyen Y, DiTullio Jr RA, Snyder A, Venere M, Stavridi ES, Halazonetis TD. ATM signaling and 53BP1. Radiother Oncol 2005; 76:119-22.
-
(2005)
Radiother Oncol
, vol.76
, pp. 119-122
-
-
Zgheib, O.1
Huyen, Y.2
DiTullio Jr., R.A.3
Snyder, A.4
Venere, M.5
Stavridi, E.S.6
Halazonetis, T.D.7
-
90
-
-
0036261707
-
Sensing and repairing DNA double-strand breaks
-
Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002; 23:687-96.
-
(2002)
Carcinogenesis
, vol.23
, pp. 687-696
-
-
Jackson, S.P.1
-
91
-
-
0034679076
-
Cancer risk and the ATM gene: A continuing debate
-
Khanna KK. Cancer risk and the ATM gene: A continuing debate. J Natl Cancer Inst 2000; 92:795-802.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 795-802
-
-
Khanna, K.K.1
-
92
-
-
0033229933
-
ATM: A mediator of multiple responses to genotoxic stress
-
Rotman G, Shiloh Y. ATM: A mediator of multiple responses to genotoxic stress. Oncogene 1999; 18:6135-44.
-
(1999)
Oncogene
, vol.18
, pp. 6135-6144
-
-
Rotman, G.1
Shiloh, Y.2
-
93
-
-
0037417373
-
Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response
-
Kao GD, McKenna WG, Guenther MG, Muschel RJ, Lazar MA, Yen TJ. Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response. J Cell Biol 2003; 160:1017-27.
-
(2003)
J Cell Biol
, vol.160
, pp. 1017-1027
-
-
Kao, G.D.1
McKenna, W.G.2
Guenther, M.G.3
Muschel, R.J.4
Lazar, M.A.5
Yen, T.J.6
-
94
-
-
0033615547
-
Sensing of ionizing radiation-induced DNA damage by ATM through interaction with histone deacetylase
-
Kim GD, Choi YH, Dimtchev A, Jeong SJ, Dritschilo A, Jung M. Sensing of ionizing radiation-induced DNA damage by ATM through interaction with histone deacetylase. J Biol Chem 1999; 274:31127-30.
-
(1999)
J Biol Chem
, vol.274
, pp. 31127-31130
-
-
Kim, G.D.1
Choi, Y.H.2
Dimtchev, A.3
Jeong, S.J.4
Dritschilo, A.5
Jung, M.6
-
95
-
-
0038243113
-
Histone deacetylase inhibitors activate p21 (WAF1) expression via ATM
-
Ju R, Muller MT. Histone deacetylase inhibitors activate p21 (WAF1) expression via ATM. Cancer Res 2003; 63:2891-7.
-
(2003)
Cancer Res
, vol.63
, pp. 2891-2897
-
-
Ju, R.1
Muller, M.T.2
-
96
-
-
0033517797
-
Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4
-
Schmidt DR, Schreiber SL. Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4. Biochemistry 1999; 38:14711-7.
-
(1999)
Biochemistry
, vol.38
, pp. 14711-14717
-
-
Schmidt, D.R.1
Schreiber, S.L.2
-
97
-
-
0034676439
-
Deacetylation of p53 modulates its effect on cell growth and apoptosis
-
Luo J, Su F, Chen D, Shiloh A, Gu W. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 2000; 408:377-81.
-
(2000)
Nature
, vol.408
, pp. 377-381
-
-
Luo, J.1
Su, F.2
Chen, D.3
Shiloh, A.4
Gu, W.5
-
98
-
-
0034617261
-
Histone deacetylases specifically downregulate p53-dependent gene activation
-
Juan LJ, Shia WJ, Chen MH, Yang WM, Seto E, Lin YS, Wu CW. Histone deacetylases specifically downregulate p53-dependent gene activation. J Biol Chem 2000; 275:20436-43.
-
(2000)
J Biol Chem
, vol.275
, pp. 20436-20443
-
-
Juan, L.J.1
Shia, W.J.2
Chen, M.H.3
Yang, W.M.4
Seto, E.5
Lin, Y.S.6
Wu, C.W.7
-
99
-
-
27644543144
-
The role of the BRCA1 tumor suppressor in DNA double-strand break repair
-
Zhang J, Powell SN. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res 2005; 3:531-9.
-
(2005)
Mol Cancer Res
, vol.3
, pp. 531-539
-
-
Zhang, J.1
Powell, S.N.2
-
100
-
-
15744392173
-
Homologous recombination: Needing to have my say
-
Okada T, Keeney S. Homologous recombination: Needing to have my say. Curr Biol 2005; 15:R200-2.
-
(2005)
Curr Biol
, vol.15
-
-
Okada, T.1
Keeney, S.2
-
101
-
-
3242886313
-
Homologous recombination-mediated double-strand break repair
-
Amst
-
Wyman C, Ristic D, Kanaar R. Homologous recombination-mediated double-strand break repair. DNA Repair (Amst) 2004; 3:827-33.
-
(2004)
DNA Repair
, vol.3
, pp. 827-833
-
-
Wyman, C.1
Ristic, D.2
Kanaar, R.3
-
102
-
-
13944268723
-
The RAD51 gene family, genetic instability and cancer
-
Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett 2005; 219:125-35.
-
(2005)
Cancer Lett
, vol.219
, pp. 125-135
-
-
Thacker, J.1
-
103
-
-
0022827675
-
Mechanism of interaction between Ku protein and DNA
-
Mimori T, Hardin JA. Mechanism of interaction between Ku protein and DNA. J Biol Chem 1986; 261:10375-9.
-
(1986)
J Biol Chem
, vol.261
, pp. 10375-10379
-
-
Mimori, T.1
Hardin, J.A.2
-
104
-
-
0024356877
-
HeLa nuclear protein recognizing DNA termini and translocating on DNA forming a regular DNA-multimeric protein complex
-
de Vries E, van Driel W, Bergsma WG, Arnberg AC, van der Vliet PC. HeLa nuclear protein recognizing DNA termini and translocating on DNA forming a regular DNA-multimeric protein complex. J Mol Biol 1989; 208:65-78.
-
(1989)
J Mol Biol
, vol.208
, pp. 65-78
-
-
De Vries, E.1
Van Driel, W.2
Bergsma, W.G.3
Arnberg, A.C.4
Van Der Vliet, P.C.5
-
105
-
-
0031930488
-
DNA-dependent protein kinase: DNA binding and activation in the absence of Ku
-
USA
-
Hammarsten O, Chu G. DNA-dependent protein kinase: DNA binding and activation in the absence of Ku. Proc Natl Acad Sci USA 1998; 95:525-30.
-
(1998)
Proc Natl Acad Sci
, vol.95
, pp. 525-530
-
-
Hammarsten, O.1
Chu, G.2
-
106
-
-
0032509097
-
Cryo-EM imaging of the catalytic subunit of the DNA-dependent protein kinase
-
Chiu CY, Cary RB, Chen DJ, Peterson SR, Stewart PL. Cryo-EM imaging of the catalytic subunit of the DNA-dependent protein kinase. J Mol Biol 1998; 284:1075-81.
-
(1998)
J Mol Biol
, vol.284
, pp. 1075-1081
-
-
Chiu, C.Y.1
Cary, R.B.2
Chen, D.J.3
Peterson, S.R.4
Stewart, P.L.5
-
108
-
-
0037019597
-
The Greek goddess, Artemis, reveals the secrets of her cleavage
-
Amst
-
Jeggo P, O'Neill P. The Greek goddess, Artemis, reveals the secrets of her cleavage. DNA Repair (Amst) 2002; 1:771-7.
-
(2002)
DNA Repair
, vol.1
, pp. 771-777
-
-
Jeggo, P.1
O'Neill, P.2
-
109
-
-
0030811523
-
Yeast DNA ligase IV mediates nonhomologous DNA end joining
-
Wilson TE, Grawunder U, Lieber MR. Yeast DNA ligase IV mediates nonhomologous DNA end joining. Nature 1997; 388:495-8.
-
(1997)
Nature
, vol.388
, pp. 495-498
-
-
Wilson, T.E.1
Grawunder, U.2
Lieber, M.R.3
-
110
-
-
0030849085
-
Identification of Saccharomyces cerevisiae DNA ligase IV: Involvement in DNA double-strand break repair
-
Teo SH, Jackson SP. Identification of Saccharomyces cerevisiae DNA ligase IV: Involvement in DNA double-strand break repair. Embo J 1997; 16:4788-95.
-
(1997)
Embo J
, vol.16
, pp. 4788-4795
-
-
Teo, S.H.1
Jackson, S.P.2
-
111
-
-
4444278103
-
Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy
-
Chung YL, Wang AJ, Yao LF. Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy. Mol Cancer Ther 2004; 3:317-25.
-
(2004)
Mol Cancer Ther
, vol.3
, pp. 317-325
-
-
Chung, Y.L.1
Wang, A.J.2
Yao, L.F.3
-
112
-
-
0025228531
-
The skin: Its structure and response to ionizing radiation
-
Hopewell JW. The skin: Its structure and response to ionizing radiation. Int J Radiat Biol 1990; 57:751-773.
-
(1990)
Int J Radiat Biol
, vol.57
, pp. 751-773
-
-
Hopewell, J.W.1
-
113
-
-
19944401152
-
Priority list of research areas for radiological nuclear threat countermeasures
-
Pellmar TC, Rockwell S. Priority list of research areas for radiological nuclear threat countermeasures. Radiat Res 2005; 163:115-23.
-
(2005)
Radiat Res
, vol.163
, pp. 115-123
-
-
Pellmar, T.C.1
Rockwell, S.2
-
114
-
-
0348017184
-
Experts advise on potassium iodide use: No protection against "dirty bombs"
-
Vastag B. Experts advise on potassium iodide use: No protection against "dirty bombs". JAMA 2003; 289:2058.
-
(2003)
JAMA
, vol.289
, pp. 2058
-
-
Vastag, B.1
-
115
-
-
26844492808
-
Radiation protectants: Current status and future prospects
-
Seed TM. Radiation protectants: Current status and future prospects. Health Phys 2005; 89:531-45.
-
(2005)
Health Phys
, vol.89
, pp. 531-545
-
-
Seed, T.M.1
-
116
-
-
13844280895
-
Amifostine (ETHYOL) protects rats from mucositis resulting from fractionated or hyperfractionated radiation exposure
-
Cassatt DR, Fazenbaker CA, Bachy CM, Kifle G, McCarthy MP. Amifostine (ETHYOL) protects rats from mucositis resulting from fractionated or hyperfractionated radiation exposure. Int J Radiat Oncol Biol Phys 2005; 61:901-7.
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.61
, pp. 901-907
-
-
Cassatt, D.R.1
Fazenbaker, C.A.2
Bachy, C.M.3
Kifle, G.4
McCarthy, M.P.5
-
118
-
-
5144231707
-
A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy
-
Metz JM, Smith D, Mick R, Lustig R, Mitchell J, Cherakuri M, Glatstein E, Hahn SM. A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy. Clin Cancer Res 2004; 10:6411-7.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 6411-6417
-
-
Metz, J.M.1
Smith, D.2
Mick, R.3
Lustig, R.4
Mitchell, J.5
Cherakuri, M.6
Glatstein, E.7
Hahn, S.M.8
-
119
-
-
0021736288
-
Modification of the radiation sensitivity of human tumour cells by a bis-benzimidazole derivative
-
Smith PJ, Anderson CO. Modification of the radiation sensitivity of human tumour cells by a bis-benzimidazole derivative. Int J Radiat Biol Relat Stud Phys Chem Med 1984; 46:331-44.
-
(1984)
Int J Radiat Biol Relat Stud Phys Chem Med
, vol.46
, pp. 331-344
-
-
Smith, P.J.1
Anderson, C.O.2
-
120
-
-
10744222106
-
In vitro studies with methylproamine: A potent new radioprotector
-
Martin RF, Broadhurst S, Reum ME, Squire CJ, Clark GR, Lobachevsky PN, White JM, Clark C, Sy D, Spotheim-Maurizot M, Kelly DP. In vitro studies with methylproamine: A potent new radioprotector. Cancer Res 2004; 64:1067-70.
-
(2004)
Cancer Res
, vol.64
, pp. 1067-1070
-
-
Martin, R.F.1
Broadhurst, S.2
Reum, M.E.3
Squire, C.J.4
Clark, G.R.5
Lobachevsky, P.N.6
White, J.M.7
Clark, C.8
Sy, D.9
Spotheim-Maurizot, M.10
Kelly, D.P.11
-
122
-
-
0036218414
-
Irradiation induces increased production of haemopoietic and proinflammatory cytokines in the mouse lung
-
Fedorocko P, Egyed A, Vacek A. Irradiation induces increased production of haemopoietic and proinflammatory cytokines in the mouse lung. Int J Radiat Biol 2002; 78:305-13.
-
(2002)
Int J Radiat Biol
, vol.78
, pp. 305-313
-
-
Fedorocko, P.1
Egyed, A.2
Vacek, A.3
-
123
-
-
0029838436
-
Long-term expression of transforming growth factor TGF beta 1 in mouse skin after localized beta-irradiation
-
Randall K, Coggle JE. Long-term expression of transforming growth factor TGF beta 1 in mouse skin after localized beta-irradiation. Int J Radiat Biol 1996; 70:351-60.
-
(1996)
Int J Radiat Biol
, vol.70
, pp. 351-360
-
-
Randall, K.1
Coggle, J.E.2
-
124
-
-
0031779557
-
Abnormal phenotype of cultured fibroblasts in human skin with chronic radiotherapy damage
-
Delanian S, Martin M, Bravard A, Luccioni C, Lefaix JL. Abnormal phenotype of cultured fibroblasts in human skin with chronic radiotherapy damage. Radiother Oncol 1998; 47:255-61.
-
(1998)
Radiother Oncol
, vol.47
, pp. 255-261
-
-
Delanian, S.1
Martin, M.2
Bravard, A.3
Luccioni, C.4
Lefaix, J.L.5
-
125
-
-
0035162793
-
The transforming growth factor-beta signaling pathway in tumorigenesis
-
Wieser R. The transforming growth factor-beta signaling pathway in tumorigenesis. Curr Opin Oncol 2001; 13:70-7.
-
(2001)
Curr Opin Oncol
, vol.13
, pp. 70-77
-
-
Wieser, R.1
-
126
-
-
0034644472
-
TGFbeta signaling in growth control, cancer, and heritable disorders
-
Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103:295-309.
-
(2000)
Cell
, vol.103
, pp. 295-309
-
-
Massague, J.1
Blain, S.W.2
Lo, R.S.3
|